ArticleSurgical case reports2025
Left Ventricular Pseudoaneurysm Possibly Associated with Rivaroxaban Therapy Disappeared after Cessation of Rivaroxaban: Case Report and Literature Review.
Article in Surgical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAlthough iatrogenic left ventricular pseudoaneurysm (LVPA) is rare, its treatment strategy needs consideration. We report a case in which postoperative initiation of rivaroxavan led to iatrogenic LVPA, which resolved spontaneously after drug cessation. CASE PRESENTATION: A 69-year-old man was diagnosed with a 76-mm saccular aortic arch aneurysm. He underwent urgent total aortic arch replacement with a frozen elephant trunk. A left ventricular apex injury due to intraoperative vent insertion was repaired, and postoperative CT revealed no problems. While hospitalized, he developed atrial fibrillation and started taking rivaroxavan. At 3 months postoperatively, an LVPA, 10 mm in diameter, developed at the intraoperative repair site. The LVPA resolved spontaneously following discontinuation of rivaroxaban, thereby avoiding the need for reoperation.
conclusionsThis case illustrates the potential for anticoagulation-associated LVPA formation in surgically repaired myocardium and supports the consideration of conservative management in selected cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.